Granules India Limited Share Price & Technical Analysis
GRANULES · ₹752.0 (-1.60%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹752.0
-1.60%
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, su…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
7% return in May, 3% avg return in past 3 year May month.
28% return in 2026, 24% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -5% | 5% | 9% | 11% | 7% | – | – | – | – | – | – | – | 28% |
| 25 | -6% | -17% | 6% | -7% | 16% | -7% | -4% | 3% | 5% | 8% | -2% | 6% | 3% |
| 24 | 2% | 12% | -8% | -2% | -1% | 16% | 28% | 14% | -22% | 2% | 2% | 2% | 46% |
| 23 | -7% | -5% | 4% | 3% | -6% | 5% | 7% | -8% | 18% | -9% | 23% | 0% | 25% |
| 22 | -10% | -5% | 6% | -8% | -3% | 1% | 10% | 2% | 13% | 7% | -7% | -8% | -3% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Strong
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally. It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions. In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives. The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral. Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹180.66B
P/E ratio
29.78
52W high
₹773.2
52W low
₹432.6
Volume
6,67,458
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Granules India Limited share price today?
- Granules India Limited (GRANULES) last traded around ₹752.0 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does GRANULES have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for GRANULES. Download the app for real-time alerts.
- How can I analyze Granules India Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.